# V.A.C. VeraFlo™ Instillation Therapy vs V.A.C. Ulta™ Therapy on Biofilm in Chronically Infected Wounds

> **NCT02009501** · NA · COMPLETED · sponsor: **St. Luke's-Roosevelt Hospital Center** · enrollment: 20 (actual)

## Conditions studied

- Lower Extremity Wound Infected
- Venous Stasis Ulcers

## Interventions

- **DEVICE:** VAC VeraFlo with Dakins Instillation
- **DEVICE:** VAC Ulta Therapy

## Key facts

- **NCT ID:** NCT02009501
- **Lead sponsor:** St. Luke's-Roosevelt Hospital Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2015-05
- **Final completion:** 2015-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02009501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02009501, "V.A.C. VeraFlo™ Instillation Therapy vs V.A.C. Ulta™ Therapy on Biofilm in Chronically Infected Wounds". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02009501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*